RolandPSCharacteristics of systemic and topical agents implicated in toxicity of the middle and inner ear. Ear Nose Throat J2003; 82(Suppl 1):3–8 (grade A, level 1).
2.
FreemanSPrinerRElidanJ, et al. Objective method for differentiating between drug-induced vestibulotoxicity and cochleotoxicity. Otol Neurotol2001; 22: 70–5 (grade A, level 1).
3.
MagliuloGCianfroneGGagliardiM, et al. Vestibular evoked myogenic potentials and distortion-product otoacoustic emissions combined with glycerol testing in endolymphatic hydrops: their value in early diagnosis. Ann Otol Rhinol Laryngol2004; 113: 1000–5 (grade B, level 2).
4.
MagliuloGGagliardiMParrottoD, et al. Preservation of vestibular myogenic potentials with modified translabyrinthine approach. Arch Otolaryngol (in press).
5.
NakashimaTTeranishiMHibiT, et al. Vestibular and cochlear toxicity of aminoglycosides—a review. Acta Otolaryngol2000; 120: 904–11 (grade A, level 1).
